Wright Don - 14 Jun 2023 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Director
Signature
/s/ Russell Kern, Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
14 Jun 2023
Net transactions value
$0
Form type
4
Filing time
16 Jun 2023, 17:23:47 UTC
Previous filing
10 Jun 2022
Next filing
13 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 14 Jun 2023 Common Stock 30,000 $0.1400 Direct F1
transaction ISCO Stock Option (Right to Buy) Award $0 +445,205 $0.000000 445,205 14 Jun 2023 Common Stock 445,205 $0.1400 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest fully at the earlier of (i) 06/14/2024 or (ii) the date of the 2024 Annual Meeting of Stockholders.
F2 Options vest in four equal quarterly increments, beginning 09/14/2023.